Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Agartala: Tripura Police apprehended a suspect and confiscated banned cough syrup phensedyl valued at Rs 30 lakh from Dhalai District.

The operation, spearheaded by Dhalai Superintendent of Police, Avinash Rai, unfolded in the early hours of Friday. Acting on undisclosed intelligence, a joint team comprising Dhalai District Police, Tripura State Rifles, and Border Security Force intercepted a truck traveling from West Bengal to Agartala.

Detailing the operation, Rai explained, “Upon reaching the Ambassa naka checking point, we intercepted the vehicle, ostensibly loaded with household commodities. However, a thorough inspection revealed a hidden cache—60 cartons containing approximately 6,000 bottles of banned cough syrup, specifically Phensedyl, with an estimated market value of Rs 30 lakh.”

Subsequently, the police detained the driver and initiated legal proceedings against him. “We have presented the suspect before the court, seeking police remand for further interrogation,” Rai confirmed.

Related Posts

  • Pharma
  • February 17, 2025
  • 84 views
GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals Ltd…

  • Pharma
  • February 17, 2025
  • 74 views
Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Shares of Glenmark Pharmaceuticals Ltd rose 4% on February 17 after the firm gave a strong guidance for FY26 and it returned to black in the December quarter. The drugmaker…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wow! What a Change of Heart in Practitioners of Allopathy!

Wow! What a Change of Heart in Practitioners of Allopathy!

GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gain 20% following strong Q3FY25 results

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

US Tariffs on pharma: What are the potential impact on Indian drugmakers

US Tariffs on pharma: What are the potential impact on Indian drugmakers

Twin Health bats a1000 before enters Digital Health NY 100

Twin Health bats a1000 before enters Digital Health NY 100

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%